Claims for Patent: 5,346,889
✉ Email this page to a colleague
Summary for Patent: 5,346,889
Title: | Process for extracting endotoxin |
Abstract: | A solution containing at least one of albumin and globulin is effective for extracting endotoxin adhered to or adsorbed on a surface of a solid such as containers, medical devices, disposable needles, etc., and thus useful as a cleaning agent for these containers, medical devices, etc. |
Inventor(s): | Tsuchiya; Masakazu (Amagasaki, JP), Takaoka; Aya (Amagasaki, JP), Harada; Kazuaki (Amagasaki, JP) |
Assignee: | Wako Pure Chemical Industries, Ltd. (Osaka, JP) |
Application Number: | 07/991,214 |
Patent Claims: | 1. A process for extracting endotoxin adhered to or adsorbed on a surface of a container or device, which comprises contacting the container or device with a solution
comprising at least one of albumin and globulin.
2. A process according to claim 1, wherein the solution comprises albumin. 3. A process according to claim 2, wherein the albumin is human serum albumin. 4. A process according to claim 3, wherein the human serum albumin is contained in an amount of 0.0001 to 0.5% w/v. 5. A process according to claim 2, wherein the solution comprising albumin is a plasma solution or serum solution. 6. A process according to claim 1, wherein at least one of albumin and globulin is contained in the solution in a concentration of 0.0001 to 6 mg/ml in terms of protein concentration. 7. A process according to claim 1, wherein the albumin and globulin are previously autoclaved to remove endotoxins. 8. A solution for extracting endotoxin adhered to or adsorbed on a surface of a solid, which comprises an endotoxin-free water or buffer solution and at least one of albumin and globulin in a concentration of 0.0001 to 6 mg/ml in terms of protein concentration. 9. A solution according to claim 8, which contains albumin. 10. A solution according to claim 9, which contains albumin is human serum albumin. 11. A solution according to claim 10, which contains human serum albumin is contained in an amount of 0.0001 to 0.5% w/v. 12. A solution according to claim 9, which contains solution containing albumin is a plasma solution or a serum solution. 13. A solution according to claim 8, wherein the albumin and globulin are previously autoclaved to remove endotoxins. 14. A process for cleaning containers or devices contaminated with endotoxin, which comprises rinsing the containers or devices using a solution comprising at least one of albumin and globulin. 15. A process according to claim 14, wherein the solution contains albumin. 16. A process according to claim 15, wherein the albumin is human serum albumin. 17. A process according to claim 16, wherein the human serum albumin is used in an amount of 0.0001 to 0.5% w/v. 18. A process according to claim 15, wherein the solution containing albumin is a plasma solution or serum solution. 19. A process according to claim 14, wherein at least one of albumin and globulin is contained in the solution in a concentration of 0.0001 to 6 mg/ml in terms of protein concentration. 20. A process according to claim 14, wherein the albumin and globulin are previously autoclaved to remove endotoxins. 21. A cleaning agent for cleaning containers or devices contaminated with endotoxin, which comprises an endotoxin-free water or buffer solution and at least one of albumin and globulin in a concentration of 0.0001 to 6 mg/ml in terms of protein concentration. 22. A cleaning agent according to claim 21, which is a solution containing albumin. 23. A cleaning agent according to claim 22, wherein the albumin is human serum albumin. 24. A cleaning agent according to claim 23, wherein the human serum albumin is used in an amount of 0.0001 to 0.5% w/v. 25. A cleaning agent according to claim 22, wherein the solution containing albumin is a plasma solution or serum solution. 26. A cleaning agent according to claim 21, wherein the albumin and globulin are previously autoclaved to remove endotoxins. |
Details for Patent 5,346,889
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2011-12-24 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2011-12-24 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2011-12-24 |
Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2011-12-24 |
Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 02/17/1995 | ⤷ Try a Trial | 2011-12-24 |
Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 06/11/2003 | ⤷ Try a Trial | 2011-12-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.